GlassScriptPhysician profile
Jordan Forbush
NPI 1821680166
$929.50
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $653 · 2022: $177 · 2023: $39.48 · 2024: $59.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $212.27 | 2021-2022 | |
| Actelion Pharmaceuticals US, INC. | $118.30 | 2021 | |
| Medtronic, INC. | $85.14 | 2022-2024 | Signia |
| E.R. Squibb & Sons, L.L.C. | $79.34 | 2021 | |
| Jazz Pharmaceuticals INC. | $77.47 | 2021 | |
| Amgen INC. | $72.26 | 2022 | |
| Sanofi Pasteur INC. | $39.48 | 2023 | |
| Lilly USA, LLC | $37.26 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.15 | 2021 | |
| Boston Scientific Corporation | $29.09 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $24.23 | 2021 | |
| Organon LLC | $19.07 | 2022 | |
| Arbor Pharmaceuticals, INC. | $16.65 | 2021 | |
| Ironshore Pharmaceuticals INC. | $15.97 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.40 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $14.16 | 2021 | |
| Coala Life INC | $13.95 | 2021 | |
| Impel Pharmaceuticals INC. | $13.81 | 2022 | |
| Vistapharm, INC. | $12.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jordan Forbush listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.